Drug Discovery for Human African Trypanosomiasis: Target-Based and Phenotypic Approaches

Tue2  Sep03:00pm(30 mins)
Charter 2
 Ian Gilbert


Human African trypanosomiasis is a fatal infection, prevalent in sub-Saharan Africa. There is a need for new drugs to treat this disease, to support treatment and an eradication agenda. In the Drug Discovery Unit, we have run a programme to identify potential drug candidates for this disease. These have been run as both target-based programmes and phenotypic programmes. In this presentation, I will summarise some of our experiences and discuss the advantages and disadvantages of both approaches.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021